Last reviewed · How we verify
NCT05307601: IMMUNOVIDIAL
Immune Response Following COVID-19 in Hemodialysis Patients
trial in Dialysis; Complications in 21 participants. Completed in 30 October 2021.
1 September 2021
Quick facts
| Lead sponsor | AURA Paris |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 21 |
| Start date | 1 September 2020 |
| Primary completion | 1 September 2021 |
| Estimated completion | 30 October 2021 |
| Sites | 1 location across France |
Conditions studied
- Dialysis; Complications — all drugs for Dialysis; Complications →
- COVID-19 — all drugs for COVID-19 →
- Cytokine Storm — all drugs for Cytokine Storm →
Sponsor
AURA Paris
Who can join
18 and older, any sex, with Dialysis; Complications or COVID-19. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Patients with chronic kidney disease (CKD), particularly those undergoing hemodialysis (HD), are at high risk of a severe form of COVID-19. This study aims to characterize the inflammatory and antiviral response during SarsCov2 infection in adult
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05307601
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Dialysis; Complications
Currently open trials in the same condition.
- NCT07412834 — Safely Disconnect From the Dialysis Machine in an Emergency Situation · active not recruiting
- NCT03629977 — Timing of Renal Replacement Therapy in the Critically Ill Patients · recruiting
- NCT07045155 — Pegmolesatide Treatment for Anemia in Patients Undergoing Long-term Dialysis · Phase 4 · recruiting
- NCT05490225 — Access Cannulation Trial II · NA · recruiting
- NCT05418647 — Effect of Low Versus High Dialysate Sodium Concentration During Hemodialysis on Dialysis Recovery Time · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05307601 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by AURA Paris
- Last refreshed: 1 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05307601.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing